Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
Clinical trial NCT01605773 · COMPLETED
Trial details
- NCT number
- NCT01605773
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-08
- Primary completion
- 2003-03-13
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.